Drug intelligence / Profile preview

N-beta-D-glucopyranosylacetamide

Development stage
Unknown
Modality
Small Molecules
01

Overview

N-beta-D-glucopyranosylacetamide is a synthetic small molecule belonging to the class of hexoses (six-carbon monosaccharides). It is structurally related to glucose derivatives and acts as an experimental inhibitor of glycogen phosphorylase, specifically the muscle form. By inhibiting this enzyme, it can potentially modulate glycogen metabolism. The compound has been studied primarily in biochemical and structural contexts as a tool compound for understanding enzyme inhibition but has not advanced into clinical development or therapeutic use[2][5]. Its main research interest lies in its potential as a lead structure for designing antihyperglycemic agents.

Other names
1-N-acetyl-beta-D-glucosamineN-Acetyl-beta-D-glucopyranosylamineN-Acétyl-β-D-glucopyranosylamineβ-D-Glucopyranosylamine, N-acetyl-Acetamide, N-beta-D-glucopyranosyl-6983-36-4
02

Targets

PYGM (Glycogen phosphorylase, muscle form)

Beyond the preview

Go deeper on N-beta-D-glucopyranosylacetamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-beta-D-glucopyranosylacetamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call